Main Content start here
Main Layout
Report Description

Report Description

Key Insights

Details

Forecast Period

2027-2031

Market Size (2025)

USD 74.15 Billion

CAGR (2026-2031)

6.49%

Fastest Growing Segment

Infant Formula

Largest Market

North America

Market Size (2031)

USD 108.13 Billion

Market Overview

The Global Infant Nutrition Market is projected to grow from USD 74.15 Billion in 2025 to USD 108.13 Billion by 2031 at a 6.49% CAGR. The Global Infant Nutrition Market encompasses a diverse range of products specifically formulated to meet the unique dietary requirements of infants from birth up to 12 months, including infant formula, follow-on formula, and specialized complementary foods designed for optimal growth and development. Market expansion is primarily driven by increasing global birth rates, rising disposable incomes in emerging economies, and heightened parental awareness regarding the critical importance of early childhood nutrition for long-term health outcomes. Additionally, the growing participation of women in the global workforce contributes to increased demand for convenient, pre-prepared infant feeding solutions.

A significant challenge impeding market growth remains the stringent regulatory frameworks governing product composition, safety standards, and marketing practices across various jurisdictions. These regulations necessitate substantial investment in research and development and compliance monitoring. According to the International Dairy Federation, world milk production is expected to surpass a billion tonnes in 2025, highlighting the foundational raw material supply for a significant segment of infant nutrition products.

Key Market Drivers

Growing Parental Awareness and Demand for Specialized Infant Nutrition
Increasing parental awareness of infant health and nutrition significantly propels the global infant nutrition market as caregivers prioritize optimal early childhood development. This heightened focus extends beyond basic sustenance to specialized formulations addressing specific health needs and developmental outcomes. Parents are increasingly recognizing the health benefits of appropriate feeding practices, which impacts their choices regarding both breastfeeding and complementary feeding solutions. According to UNICEF Data, August 2025, in 'The State of Food Security and Nutrition in the World 2025,' the percentage of infants under six months exclusively breastfed increased to 47.8% in 2023, reflecting a growing understanding of critical early nutrition. This trend also supports demand for infant nutrition products designed to complement or supplement breastfeeding, focusing on ingredients that promote immunity and cognitive development.

Rising Female Workforce Participation and Market Premiumization
Concurrently, rising female workforce participation and the prevalence of dual-income households contribute substantially to market expansion by increasing the demand for convenient and high-quality infant feeding solutions. As more women enter or remain in the professional sphere, the need for readily available and nutritionally complete options like infant formula becomes more pronounced. According to Trading Economics, May 2026, citing the World Bank, the female labor force comprised 40.24% of the total global labor force in 2024, highlighting the widespread engagement of women in economic activities. This demographic shift supports the premiumization trend, as households with higher disposable incomes are often more inclined to invest in advanced infant nutrition products. For the overall market, Danone reported sales of €6,708 million in the first quarter of 2026, demonstrating continued significant activity within the sector.

Download Free Sample Report

Key Market Challenges

The stringent regulatory frameworks governing product composition, safety standards, and marketing practices across various jurisdictions represent a substantial impediment to the growth of the Global Infant Nutrition Market. These complex and often divergent regulations necessitate significant investment from manufacturers in extensive research and development to ensure compliance with specific national and regional requirements. This involves rigorous testing, formulation adjustments, and detailed documentation, directly increasing operational costs and extending timelines for product development and market entry. The fragmented regulatory landscape limits the ability of manufacturers to achieve economies of scale and restricts the introduction of innovative solutions globally, thereby delaying market responsiveness to evolving consumer needs and technological advancements.

This is further compounded by trade regulations; according to the Competitive Enterprise Institute in December 2024, tariffs on foreign-produced infant formula in the United States currently range from roughly 15 percent to just over 17 percent, significantly hindering international market access and competition. These cumulative regulatory burdens ultimately constrain the overall expansion and dynamism of the infant nutrition sector.

Key Market Trends

The global infant nutrition market is experiencing a significant shift towards organic and clean-label products as parental preferences increasingly lean towards natural and transparent formulations. This trend is driven by heightened consumer scrutiny regarding ingredient provenance and a desire to minimize infant exposure to artificial additives and genetically modified organisms. Manufacturers are responding by expanding their organic offerings and emphasizing clear, understandable ingredient lists. According to DSM, one of the leading companies in infant nutrition, around 71% of parents seek clean label claims on packs, desiring ingredients they trust and know. This strong consumer demand for products perceived as healthier and safer is compelling companies to invest in sourcing and production methods that meet stringent organic and clean-label certifications, thereby influencing product development and market positioning.

Concurrently, innovation in microbiome-supporting ingredients, such as probiotics and Human Milk Oligosaccharides (HMOs), represents a pivotal trend shaping the infant nutrition landscape. These advanced ingredients aim to mimic the beneficial properties of breast milk, focusing on enhancing infant gut health, immunity, and overall development. Scientific advancements are enabling the incorporation of these complex components into infant formulas, offering additional functional benefits beyond basic nutrition. A notable development occurred in September 2025 when dsm-firmenich declared that its lacto-N-fucopentaose I/2′-fucosyllactose (LNFP-I/2′-FL) mixture and human milk oligosaccharide (HMO): 3-fucosyllactose (3-FL) received approval as novel food additives in the EU and the UK. This regulatory milestone underscores the growing acceptance and integration of such innovative ingredients, driving premiumization within the specialized nutrition segment.

Segmental Insights

The Infant Formula segment demonstrates rapid expansion within the Global Infant Nutrition Market. This growth is significantly driven by a rising number of working mothers seeking convenient and nutritionally balanced feeding solutions. Concurrently, heightened parental awareness regarding optimal infant nutrition and the continuous innovation in formula compositions, including the addition of prebiotics, probiotics, and ingredients mimicking breast milk, contribute to its increasing adoption. Furthermore, the growing demand for specialized formulations, such as organic or hypoallergenic options, caters to diverse infant needs and parental preferences for high-quality products.

Regional Insights

North America stands as the leading region within the global infant nutrition market, attributed to its well-developed healthcare infrastructure and high consumer awareness regarding infant health. The region's dominance is further strengthened by the strong adoption of premium and specialized nutrition products, including organic and hypoallergenic options. Robust regulatory oversight by bodies such as the U.S. Food and Drug Administration (FDA) ensures product safety and quality, fostering significant consumer trust. Additionally, high disposable incomes and a strong retail presence facilitate easy access to a diverse range of infant nutrition solutions, supporting sustained market leadership.

Recent Developments

  • In March 2026, FrieslandCampina outlined strategic priorities, including a focus on strengthening its competitive edge in the infant nutrition ingredients space. This involved expanding whey processing capacities, significantly bolstered by the prior acquisition of Wisconsin Whey Protein. This acquisition was a key strategic move, increasing the cooperative's production capacity for high-value protein ingredients like whey protein isolate and concentrate. This expansion positioned FrieslandCampina to enhance its role in high-growth segments such as infant nutrition, ensuring a more robust supply of essential components for various specialized nutritional products globally.
  • In August 2025, Abbott announced significant advancements in its infant formula research, particularly regarding Similac 360 Total Care with five Human Milk Oligosaccharides (HMOs). A large-scale clinical study confirmed that this formula delivered clinical benefits in gut health, immune support, and brain development, showing outcomes comparable to breastfed infants. This breakthrough research aimed to further mirror breast milk’s essential benefits in infant formula, reinforcing Abbott's commitment to scientific innovation within the global infant nutrition market. The findings were poised for publication, highlighting ongoing efforts to advance science-based nutrition for infants worldwide.
  • In June 2025, Nestlé introduced NAN Sinergity, a new infant formula poised to be a significant contributor to the company’s growth in the global infant nutrition market. This innovative product is unique as it is the only infant formula globally to combine six human milk oligosaccharides (HMOs) with the probiotic Bifidobacterium infantis. The formulation was developed to support immunity, growth, brain development, bone health, muscle development, and digestion. Nestlé aimed to capture opportunities in the premium and super-premium formula segments with this scientifically backed offering.
  • In February 2025, Kendamil expanded its presence in the infant nutrition market by launching a new formula brand, Bonya, in the United Kingdom. This initiative aimed to provide high-quality infant formula at a more accessible price point, particularly for families facing cost-of-living challenges. Bonya, developed by the family behind Kendamil, sought to offer quality ingredients with industry-leading pricing, including eligibility for NHS Healthy Start vouchers. This strategic launch demonstrated Kendamil’s commitment to providing affordable and nutritious options within the competitive infant formula sector.

Key Market Players

  • Nestlé S.A.
  • Danone S.A.
  • Abbott Laboratories
  • Reckitt Benckiser Group plc
  • Mead Johnson Nutrition Company
  • Royal FrieslandCampina N.V.
  • Arla Foods amba
  • Fonterra Co-operative Group Limited
  • The a2 Milk Company Limited
  • Perrigo Company Plc

By Product

By Infant Formula

By Region

  • Infant Formula
  • Ba
  • First Infant Formula
  • Follow-on Formula
  • Growing-up Formula
  • Specialty Ba
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Infant Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Infant Nutrition Market, By Product:
  • Infant Formula
  • Ba
  • Infant Nutrition Market, By Infant Formula:
  • First Infant Formula
  • Follow-on Formula
  • Growing-up Formula
  • Specialty Ba
  • Infant Nutrition Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infant Nutrition Market.

Available Customizations:

Global Infant Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Infant Nutrition Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Infant Nutrition Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Product (Infant Formula, Ba)

5.2.2.  By Infant Formula (First Infant Formula, Follow-on Formula, Growing-up Formula, Specialty Ba)

5.2.3.  By Region

5.2.4.  By Company (2025)

5.3.  Market Map

6.    North America Infant Nutrition Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product

6.2.2.  By Infant Formula

6.2.3.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Infant Nutrition Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Product

6.3.1.2.2.  By Infant Formula

6.3.2.    Canada Infant Nutrition Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Product

6.3.2.2.2.  By Infant Formula

6.3.3.    Mexico Infant Nutrition Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Product

6.3.3.2.2.  By Infant Formula

7.    Europe Infant Nutrition Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Product

7.2.2.  By Infant Formula

7.2.3.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Infant Nutrition Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Product

7.3.1.2.2.  By Infant Formula

7.3.2.    France Infant Nutrition Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Product

7.3.2.2.2.  By Infant Formula

7.3.3.    United Kingdom Infant Nutrition Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Product

7.3.3.2.2.  By Infant Formula

7.3.4.    Italy Infant Nutrition Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Product

7.3.4.2.2.  By Infant Formula

7.3.5.    Spain Infant Nutrition Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Product

7.3.5.2.2.  By Infant Formula

8.    Asia Pacific Infant Nutrition Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Product

8.2.2.  By Infant Formula

8.2.3.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Infant Nutrition Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Product

8.3.1.2.2.  By Infant Formula

8.3.2.    India Infant Nutrition Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Product

8.3.2.2.2.  By Infant Formula

8.3.3.    Japan Infant Nutrition Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Product

8.3.3.2.2.  By Infant Formula

8.3.4.    South Korea Infant Nutrition Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Product

8.3.4.2.2.  By Infant Formula

8.3.5.    Australia Infant Nutrition Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Product

8.3.5.2.2.  By Infant Formula

9.    Middle East & Africa Infant Nutrition Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Product

9.2.2.  By Infant Formula

9.2.3.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Infant Nutrition Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Product

9.3.1.2.2.  By Infant Formula

9.3.2.    UAE Infant Nutrition Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Product

9.3.2.2.2.  By Infant Formula

9.3.3.    South Africa Infant Nutrition Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Product

9.3.3.2.2.  By Infant Formula

10.    South America Infant Nutrition Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Infant Formula

10.2.3.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Infant Nutrition Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Product

10.3.1.2.2.  By Infant Formula

10.3.2.    Colombia Infant Nutrition Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Product

10.3.2.2.2.  By Infant Formula

10.3.3.    Argentina Infant Nutrition Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Product

10.3.3.2.2.  By Infant Formula

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Infant Nutrition Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Nestlé S.A.

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Danone S.A.

15.3.  Abbott Laboratories

15.4.  Reckitt Benckiser Group plc

15.5.  Mead Johnson Nutrition Company

15.6.  Royal FrieslandCampina N.V.

15.7.  Arla Foods amba

15.8.  Fonterra Co-operative Group Limited

15.9.  The a2 Milk Company Limited

15.10.  Perrigo Company Plc

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Infant Nutrition Market was estimated to be USD 74.15 Billion in 2025.

North America is the dominating region in the Global Infant Nutrition Market.

Infant Formula segment is the fastest growing segment in the Global Infant Nutrition Market.

The Global Infant Nutrition Market is expected to grow at 6.49% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.